U.S. market Closed. Opens in 4 hours 14 minutes

RLAY | Relay Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue25.55M1.38M3.03M82.65MN/AN/A
Cost of Revenue5.27M4.13M3.92M3.55M2.85MN/A
Gross Profit20.28M-2.75M-896.00K79.11M-2.85MN/A
Operating Expenses404.97M312.33M230.04M138.45M84.05M49.89M
Selling, General & Admin74.95M65.98M57.39M38.59M13.74M8.86M
Research & Development330.02M246.35M172.65M99.86M70.31M41.03M
Other Operating Expenses-18.00K-20.00K-4.00K-16.00K-58.00K-9.00K
Operating Income-373.00M-299.27M-364.70M-55.80M-84.05M-49.89M
Other Expenses / Income6.40M8.77M826.00K3.38M8.74M1.10M
Before Tax Income-341.97M-290.51M-363.87M-52.41M-75.31M-48.78M
Income Tax Expenses-37.47M-36.25M132.94M-3.40M-8.80M1.10M
Net Income-341.97M-254.26M-496.81M-49.01M-66.50M-48.78M
Interest ExpensesN/A-8.77MN/AN/AN/AN/A
Basic Shares Outstanding122.58M112.23M95.14M42.62M4.28M2.49M
Diluted Shares Outstanding122.58M112.23M95.14M42.62M4.28M2.49M
EBITDA-380.57M-322.63M-89.32M-52.25M-81.20M-46.63M
EBITDA Margin-1,489.76%-23,361.98%-2,948.70%-63.21%0.00%0.00%
EBIT-379.44M-299.27M-363.87M-52.41M-75.31M-47.68M
EBIT Margin-1,485.32%-21,670.89%-12,012.94%-63.41%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙